Member Info for tuan6

You need to understand he form 7 companys until now. He got lot more to get and have more understand the law on company act than any of you. Face with it. Before abadon ship he take 8 millions share more so only let share holder take responsibility and he is enjoying sun sight at his home in Switzerland.

He is not living in UK yes. All work from his country so no need to see shareholders 's face either.

1.4 is coming near than people hope too.

You don't need buy now . Wait at 3.40 today buy at 1 4 p cheaper than 1.6 now

No double

That is only bad situation when no deal and very shor time down price. In fact Hemo hold 6 projects very huge on market if they can pass the research phase and move to trial phase . It take time and they will be successful.

Company with huge lot of IP value with the best scientist s working it will return lot more reward only time need .

There are many job need they do and with small number of staffs they can do amazing job .

There are double on future of company but in short tern they need somekind to make it better.

If they just say they are lonking for someone do PR job . share will light up instance.

The long future is bright. The coming of hope the deal at best and people with smile face aroud here when it come

Yes I hope the deal pass too and everyone does. That is news we are waiting for some times after three extensios .

The share will fireworks if they have say in the day it out and we are too. Looking for this kind of extcing is very reward

All the best will come one day. Time will come nearer to its destination.

The Company intends to use the remainder of the received funds from the Financing Facility for the development of its other product candidates. For example, the Company may use these funds to complete IND-enabling pre-clinical studies for its CDX antibody, if necessary, in the event that GlobalCo declines to exercise its option to license the intellectual property necessary to exploit the CDX antibody, as discussed above. If, in the alternative, these funds are not needed for CDX antibody development,

I dont want to be negative but this is in RNS the plant said clearly in event there is no deal Hemo will do an IND and share will be down 3p that is the worse situation we face . In long term it will back up but the deals is 60/40 for me .

There is no warranty deal pass at this stage and we are all hope the deal pass. This is two side we need to prepare on both .

In the end Hemo will sell it products to big pharma for the IP holder with successful treatment . This road will need to go through three phases and difficulty one.

That is all hope of share holder we will get back the best from investment point of view.

When the whole UK vaccine finish this virus will bee treated as flu virus and every year people will have vaccine regular.they dont need to filter all kind of thing as people hope to use this copper nano kill viruses.

There are some usefulness in hearth care and limited in other use. Dont hope too much and there are many mask can kill virut out there

When this time pass and slowly come back normal . Everything will go on its purpose this is good in in some situation but not massive requirements .

Come back from start . When will maks will hit market ? What do sell term work at moment to promote mask and looking for distribution? How to hide staffs to manufacture mask 24/7 on running and admin work? A lot amateur people cant do job as they don't have experience to do that .

Next 1 p and start counting for 14 days left

Mhc will be next master rise . Testing for all flights and people after lockdown will go holiday a lot . Huge market on next demand.

Remember 250 billion stay in the bank of Uk and people need some way to spend with that. From 9/21 holiday will boom when vaccination whole UK finish.nothing keep people in here. Please two years not go holiday day drive people mad.see that side of opportunity .

Remember 25% share free float so everything will move fast. Down or up and then news will push this share fly instance.

Dont worry about shorter.if they loss money that is good and hemo share holder is wellcome the newso that side.

Shorter can earn money and they can find out when they close their position too. The game is on going on both sides. That is ghd whole CFD work and it will survive over the time. People will ddvelop skill to play with that.

He know how company work and can predict when it lands news. They will play on fear on share holder.

Number of share on free float very low .25% so when it hit this fly high and when they play short it down too. This is create people impatient sell for loss too.

We need some do CEO job . Vlad is scientist is well know but he can't be good on CEO . Company now grow out and expanding bigger they need hide people do different job.

If there are bod with businesses mind this company will have higher market than now and more people know it . But we are on the hard rock and it will like this way of business for time being.

Greate potential but harm down on management on direction and PR . Every company need PR on public to grow and sell products. Small or big the same but there is no charge on that role in this company.

Living with this and move or let go to different it is up to you.

All of them value billions market value if ig work as people hope. But it slows and times.

CDX with Eli, CART-T and CBR from march we will have some confirm the deal or not. Ghe rest wait next year or 2022. That is in RNS you can read it again

COVID-19 project

As announced in April 2020, Hemogenyx Pharmaceuticals is deploying its groundbreaking research capabilities and technologies to develop treatments for COVID-19. Using the exceptional characteristics of its ApbHC humanised mice, the Company seeks to discover human neutralising antibodies - antibodies that are typically developed by the human immune system to neutralise invading viral pathogens - that could be used to fight infections of SARS-CoV-2, the virus that causes COVID-19.

The Company had already been developing treatments to be deployed against other viral pathogens prior to the onset of COVID-19, both independently and with a number of pharmaceutical company partners. The Company's ApbHC mice were developed in part as a discovery platform for the development of such treatments. Hemogenyx Pharmaceuticals' scientists have been transplanting cells from blood samples from convalescent COVID-19 patients into its mice, with the goal of recreating and isolating a set of anti-SARS-CoV-2 virus antibodies.

In addition to the COVID-19 work, this initiative aims to demonstrate how the Company's technology can be deployed rapidly in emergencies in order to discover human neutralising antibodies against a host of viral pathogens, including mutations into possible new strains of COVID-19 and also what infectious disease experts in the bioprotection and biodefence sectors call "Disease X", meaning as-yet unknown viruses that may may break out and that may represent a similar or greater threat than the one presented by COVID-19.

RNS on 9/2020 they said about covid treatment but nothing update until now , Do you think they are still doing that or on hold to move to prepare on CAR-T for this late year on trial ? it is quite a long now without update on how it work or when do they start to going to trial on patient? using mice to speed up this antibody I think it should be very fast and they can speed up to , But it seem they not mention it anymore or there is nothing to say on the fund take money for continue developing that treatment.

They have some very old research with some other but it seem nothing come up and no up date too. Many thing and now the main website only have 4 main projects no say anything on covid .

Tomorrow open 1.3 and down to 1.1 let face with that for time to come.

So 83000/2 41500 jum on MXC so how many he got on MXC ? maybe he bouth 8.6 and now down it trend. ,all his money will pay MMS fee no more than that.

Next week share will be 1.1 why need buy today ? The whole hype on its pitch and now is down trend with no good news to support . Only going lowly down day after day and if you like buy in just wait next week , It is cheaper to buy than now when a lot people still jump in .

@pumpky what about RNS today perform? I hope you spent all money sold Hemo and bought in the morning all in RMS to guest a good RNS from RMS . did you ok after chase RMS? The day trader get bite today and the fund lower day after day .

83000 share convert to RMS share and now RMS lose 36% just 3 hours. that is not rights way of trade on share isnt it???

If someone like to trade share can use small fund to buy or sell share . in mean time leave this one for longer it will return good . the whole last year in trouble and Elly play with toy when they decide. When take the deal and they say extension after extension. that is not Hemo side and they could not do any thing to change it .

Without money Hemo cant go on other projects on plant that is why we did not get any news on any of the project report anything .

The BOD of Hemo decide that only new fund with a lot money can help them and cant wait the deal any more so that is why MINT come in .

Let me reminder that the value in asset on Hemo far more than 60 million worth that is why MINT can lend them with that number and Vlad confident to pay back with 10 % interest within three years.

6 months without positive news and little update what is going on and then the first extension the last 19/20 pour a cool water on share holder after waiting from 4/20 deadline through 6/20 .

when People start to enjoy little time to come the fund pop up to make a sock on when it shout be . From that point people start to reconsider the way this company give out time frame and deathlike on any project.

Indeed Hemo now have money on its bank and as soon as they finish pre work they can apply an IND going to trial without for financial from outside any more.

So in summary in this Q1 we will have to get an answer from ELLY how they want to take the deal? take it or let it go .
Hemo is preparing an IND for CBR and CAR-T at the same time but need more time until end of Q4 to go trial if you believe in good it will return .

Short term at least until Q1 there are no more exciting on any news from the deal. the CBA and CAR T having long time to come as they got money now but the company have main 2 scientists working so don't expect it quick.

It is very temp to sell when see red and loss , day after day while see a lot hot share out there . that is the life of share play and when chose the target just thing with it carefully before in or out . good luck to all holder. I am still in until got the first news .